Market Cap
¥480.74 Billion
JPY as of July 1, 2025
US$3.35 Billion
| Company | Market Cap (USD) | 
|---|---|
|  McKesson Corporation | $88.11 B | 
|  Cencora, Inc. | $56.44 B | 
|  Cardinal Health, Inc. | $38.66 B | 
|  Henry Schein, Inc. | $9.31 B | 
|  Shanghai Pharmaceuticals Holding Co. Ltd | $8.37 B | 
| Company | Market Cap (USD) | 
|---|---|
|  Lilly | $699.59 B | 
|  Johnson & Johnson | $374.29 B | 
|  AbbVie | $336.94 B | 
|  Novo Nordisk | $309.91 B | 
|  UnitedHealth Group | $279.90 B | 
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
 Japan
                        
                    
                    
                        languages
                        Healthcare
                    
                        languages
                        Medical Distribution
                            Japan
                        
                    
                    
                        languages
                        Healthcare
                    
                        languages
                        Medical Distribution
                     Japan Healthcare
                                Japan Healthcare
                        
                             Japan Medical Distribution
                            Japan Medical Distribution
                    
                    MediPal Holdings Corp has the following listings and related stock indices.
Stock: JPX: 7459
Stock: FSX: 59Z
Stock: OTC: MEPDF
Stock: OTC: MAHLY
The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.